Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial infarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial infarction registry)
dc.contributor.author | Kiris, Tuncay | |
dc.contributor.author | Avcı, Eyüp | |
dc.contributor.author | Ekin, Tuba | |
dc.contributor.author | Akgün, Didar Elif | |
dc.contributor.author | Tiryaki, Mücahit | |
dc.contributor.author | Yidirim, Arafat | |
dc.contributor.author | Hazır, Kutluhan | |
dc.contributor.author | Murat, Bektaş | |
dc.contributor.author | Yeni, Mehtap | |
dc.contributor.author | Altındağ, Rojhad | |
dc.contributor.author | Gül, Sefa | |
dc.contributor.author | Arık, Baran | |
dc.contributor.author | Güzel, Tuncay | |
dc.contributor.author | Murat, Selda | |
dc.contributor.author | Öz, Ahmet | |
dc.contributor.author | Karabacak, Mustafa | |
dc.contributor.author | Aktaş, Zihni | |
dc.contributor.author | Yıldırım, Tarık | |
dc.contributor.author | Kılıçaslan, Barış | |
dc.contributor.author | Ergene, Asim Oktay | |
dc.date.accessioned | 2021-06-17T10:31:05Z | |
dc.date.available | 2021-06-17T10:31:05Z | |
dc.date.issued | 2021 | en_US |
dc.department | Dicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kardiyoloji Ana Bilim Dalı | en_US |
dc.description | WOS:000655937200001 | |
dc.description | PMID: 34050883 | |
dc.description.abstract | Objective We aimed to investigate both the impact of COVID-19 pandemic on ST-segment elevation myocardial infarction (STEMI) admission, and demographic, angiographic, procedural characteristics, and in-hospital clinical outcomes of patients with COVID-19 positive STEMI in Turkey. Methods This was a multi-center and cross-sectional observational study. The study population included 1788 STEMI patients from 15 centers in Turkey. The patients were divided into two groups: COVID-19 era (March 11st–May 15st, 2020; n=733) or pre- COVID-19 era group (March 11st–May 15st, 2019; n=1055). Also, the patients in COVID-19 era were grouped as COVID-19 positive (n=65) or negative (n=668). Results There was a 30.5% drop in STEMI admission during COVID-19 era in comparison to pre-COVID-19 era. The patients admitted to the medical centers during COVID-19 era had a longer symptom-to-frst medical contact time [120 (75–240) vs. 100 (60–180) minutes, p<0.001]. COVID-19 positive STEMI patients had higher thrombus grade and lower left ventricular ejection fraction compared to COVID-19 negative patients. COVID-19 positive patients had higher mortality (28% vs. 6%, p<0.001) and cardiogenic shock (20% vs. 7%, p<0.001) rates compared with those without COVID-19. Matching based on propensity scores showed higher mortality and high thrombus grade in STEMI patients who were infected by SARS-COV-2 (each p<0.05). Conclusions We detected signifcantly lower STEMI hospitalization rates and signifcant delay in duration of symptom onset to frst medical contact in the context of Turkey during the COVID-19 outbreak. Moreover, high thrombus grade and mortality were more common in COVID-19 positive STEMI patients. | en_US |
dc.identifier.citation | Kiris, T., Avcı, E., Ekin, T., Akgün, D.E., Tiryaki, M., Yidirim, A. ve diğerleri. (2021). Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial infarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial infarction registry). Journal of Thrombosis and Thrombolysis, Early access. 1-14. | en_US |
dc.identifier.doi | 10.1007/s11239-021-02487-3 | |
dc.identifier.endpage | 14 | en_US |
dc.identifier.issn | 0929-5305 | |
dc.identifier.issn | 1573-742X | |
dc.identifier.pmid | 34050883 | |
dc.identifier.scopus | 2-s2.0-85107012221 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 1 | en_US |
dc.identifier.uri | https://link.springer.com/content/pdf/10.1007/s11239-021-02487-3.pdf | |
dc.identifier.uri | https://hdl.handle.net/11468/7113 | |
dc.identifier.volume | Early Access | en_US |
dc.identifier.wos | WOS:000655937200001 | |
dc.identifier.wosquality | Q2 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.institutionauthor | Arık, Baran | |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.relation.ispartof | Journal of Thrombosis and Thrombolysis | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | SARS-CoV2 | en_US |
dc.subject | ST elevation myocardial infarction | en_US |
dc.subject | Primary percutaneous coronary | en_US |
dc.subject | Intervention | en_US |
dc.subject | Mortality | en_US |
dc.title | Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial infarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial infarction registry) | en_US |
dc.title | Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial infarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial infarction registry) | |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial infarction (STEMI) in Turkey.pdf
- Boyut:
- 906.62 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Makale Dosyası
Lisans paketi
1 - 1 / 1
[ X ]
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama: